Item Type | Name |
Concept
|
Antigen-Presenting Cells
|
Concept
|
B-Lymphocytes
|
Concept
|
Dendritic Cells
|
Concept
|
T-Lymphocytes, Helper-Inducer
|
Concept
|
Killer Cells, Natural
|
Concept
|
Retinal Ganglion Cells
|
Concept
|
T-Lymphocytes
|
Concept
|
Receptors, Antigen, T-Cell
|
Concept
|
CD4-Positive T-Lymphocytes
|
Concept
|
CD8-Positive T-Lymphocytes
|
Concept
|
Th1 Cells
|
Concept
|
Th2 Cells
|
Concept
|
Receptors, Antigen, T-Cell, gamma-delta
|
Concept
|
T-Lymphocyte Subsets
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
Concept
|
T-Lymphocytes, Regulatory
|
Concept
|
Myeloid Cells
|
Concept
|
Th17 Cells
|
Concept
|
Natural Killer T-Cells
|
Concept
|
Cells, Cultured
|
Concept
|
Foam Cells
|
Academic Article
|
AP2 adaptor complex-dependent internalization of CD5: differential regulation in T and B cells.
|
Academic Article
|
Cutting edge: critical role for CD5 in experimental autoimmune encephalomyelitis: inhibition of engagement reverses disease in mice.
|
Academic Article
|
Interferon-ß exacerbates Th17-mediated inflammatory disease.
|
Academic Article
|
IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-ß in multiple sclerosis.
|
Academic Article
|
Interleukin-17 accelerates allograft rejection by suppressing regulatory T cell expansion.
|
Academic Article
|
Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunity.
|
Academic Article
|
Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein.
|
Academic Article
|
Type 1 interferons cool the inflamed brain.
|
Academic Article
|
Lithium prevents and ameliorates experimental autoimmune encephalomyelitis.
|
Academic Article
|
IFN-ß treatment requires B cells for efficacy in neuroautoimmunity.
|
Academic Article
|
Emerging Role of Follicular T Helper Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
|
Academic Article
|
Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis.
|
Academic Article
|
B cell function impacts the efficacy of IFN-ß therapy in EAE.
|
Academic Article
|
Janus-like effects of type I interferon in autoimmune diseases.
|
Academic Article
|
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice.
|
Academic Article
|
Reversal of paralysis and reduced inflammation from peripheral administration of ß-amyloid in TH1 and TH17 versions of experimental autoimmune encephalomyelitis.
|
Academic Article
|
Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica.
|
Academic Article
|
CD5-dependent CK2 activation pathway regulates threshold for T cell anergy.
|
Academic Article
|
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors.
|
Academic Article
|
Gaining entry to an uninflamed brain.
|
Academic Article
|
IL-17 contributes to the development of chronic rejection in a murine heart transplant model.
|
Academic Article
|
Inhibitory role for GABA in autoimmune inflammation.
|
Academic Article
|
T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis.
|
Academic Article
|
Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunity.
|
Academic Article
|
Angiotensin II sustains brain inflammation in mice via TGF-beta.
|
Academic Article
|
mir-181a-1/b-1 Modulates Tolerance through Opposing Activities in Selection and Peripheral T Cell Function.
|
Academic Article
|
Th17 cells induce Th1-polarizing monocyte-derived dendritic cells.
|
Academic Article
|
The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitis.
|
Academic Article
|
Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation.
|
Academic Article
|
Amelioration of ongoing experimental autoimmune encephalomyelitis with fluoxetine.
|
Academic Article
|
Role of TFH Cells in Promoting T Helper 17-Induced Neuroinflammation.
|
Academic Article
|
E3 Ubiquitin Ligase Von Hippel-Lindau Protein Promotes Th17 Differentiation.
|
Academic Article
|
Myelin-specific Th17 cells induce severe relapsing optic neuritis with irreversible loss of retinal ganglion cells in C57BL/6 mice.
|
Academic Article
|
Immunization-Expanded NKT Follicular Helper Cells Drive IgG1 Isotype Switch against an Exogenous T-Independent Polysaccharide but Do Not Promote Recall Responses.
|
Academic Article
|
Critical requirement of CD11b (Mac-1) on T cells and accessory cells for development of experimental autoimmune encephalomyelitis.
|
Academic Article
|
CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: protection is associated with diminished populations of IL-17-expressing T cells in the central nervous system.
|
Grant
|
Functional Interaction Between T-cell and B-cell Immune Pathways in Neuro- inflammatory Disorders
|
Grant
|
Molecular Stratification of Multiple Sclerosis and Associated Neuro-autoimmune Di
|
Grant
|
Pathogenic B cell and T helper cell interactions in Neuromyelitis Optica
|
Grant
|
Molecular Stratification of Multiple Sclerosis and Associated Neuro-autoimmune Di
|
Grant
|
Understanding the roles type I Interferon and TH17 play in Neuromyelitis Optica and other autoimmune diseases.
|
Academic Article
|
CNS Autoimmune Responses in BCMA-Deficient Mice Provide Insight for the Failure of Atacicept in MS.
|
Academic Article
|
Pertussis Toxin Inhibits Encephalitogenic T-Cell Infiltration and Promotes a B-Cell-Driven Disease during Th17-EAE.
|
Academic Article
|
Interferon-ß Intensifies Interleukin-23-Driven Pathogenicity of T Helper Cells in Neuroinflammatory Disease.
|
Academic Article
|
The Role of B Cells in Primary Progressive Multiple Sclerosis.
|
Academic Article
|
Antigen presentation and interferon signatures in B cells driven by localized ablative cancer immunotherapy correlate with extended survival.
|